Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride

Journal of Perinatal Medicine

Volumn 35, Issue 4, 2007, Pages 330-333

  Miyata, Masafumi ^a   Hata, Tadayoshi ^b   Kato, Noriko ^a   Takeuchi, Masatomo ^a   Mizutani, Hiroko ^a   Kubota, Masamichi ^a   Yamazaki, Toshio ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Apnea of prematurity; Atrioventricular conduction; Doxapram hydrochloride; QT interval; QT RR relationship

Indexed keywords

DOXAPRAM;

ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART CONDUCTION; HEART DEPOLARIZATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART REPOLARIZATION; HUMAN; LOW DRUG DOSE; NEWBORN APNEA; PR PROLONGATION; PREMATURITY; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RR INTERVAL; VERY LOW BIRTH WEIGHT;

CENTRAL NERVOUS SYSTEM STIMULANTS; DOXAPRAM; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; RESPIRATORY SYSTEM AGENTS; SLEEP APNEA, CENTRAL;

EID: 34447120822     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2007.068     Document Type: Article

References (20)

1. Aiba T, Shimizu W, Inagaki M, Noda T, Miyoshi S, Ding WG, et al. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol. 2005;18:300-7.
2. Anderson-Beck R, Wilson L, Brazier S, Hughes IE, Peers C. Doxapram stimulates dopamine release from the intact rat carotid body in vitro. Neurosci Lett. 1995;187:25-8.
3. Aplan G, Eyal F, Sagi E, Springer C, Patz D, Goder K. Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline. J Pediatr. 1984;104:634-7.
4. Barrington KJ, Finer NN, Peters KL, Barton J. Physiologic effects of doxapram in idiopathic apnea of prematurity. J Pediatr. 1986;108:129-9.
5. Batchvarov VN, Ghuran A, Smetana P, Hnatkova K, Harries M, Dilaveris P, et al. QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. Am J Physiol Heart Circ Physiol. 2002;282:H2356-63.
6. Benatar A, Ramet J, Decraen T, Vandenplas Y. QT interval in normal infants during sleep with concurrent evaluation of QT correction formulae. Med Sci Monit. 2003;8:351-6.
7. Chevalier P, Burri H, Adeleine P, Kirkorian G, Lopez M, Leizorovicz A, et al. QT dynamicity and sudden death after myocardial infarction: results of a long-term follow-up study. J Cardiovasc Electrophysiol. 2003;14:227-33.
8. Chiang CE. Congenital and acquired long QT syndrome. Current concepts and management. Cardiol Rev. 2004;12:222-34.
9. De Villiers GS, Walele A, Van der Merwe PI, Kalis NN. Second-degree atrioventricular heart block after doxapram administration. J Pediatr. 1998;133:149-50.
10. Drici MD, Barhanin J. Cardiac K+ channels and drug-acquired long QT syndrome. Therapie. 2000;55:185-93.
11. Friedman MJ, Mull CC, Sharieff GQ, Tsarouhas N. Prolonged QT syndrome in children: an uncommon but potentially fatal entity. J Emerg Med. 2003;24:173-9.
12. Hata T, Watanabe Y. Cellular pharmacology of AV nodal conduction and automaticity. In: Mazgalev TN, Tcho PJ, editors. Atrial-AV nodal electrophysiology: A view from the millennium. New York: Futura; 2000. p. 121.
13. Jensen BT, Larroude CE, Rasmussen LP, Holstein-Rathlou NH, Hojgaard MV, Agner E, et al. Beat-to-beat QT dynamics in healthy subjects. Ann Noninvasive Electrocardiol. 2004;9:3-11.
14. Lupoglazoff JM, Denjoy I, Villain E, Fressart V, Simon F, Bozio A, et al. Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations. J Am Coll Cardiol. 2004;43:826-30.
15. Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM. Autonomic nervous system influences on QT interval in normal subjects. J Am Coll Cardiol. 2002;39:1820-6.
16. Maillard C, Boutroy MJ, Fresson J, Barbe F, Hascoet JM. QT interval lengthening in premature infants treated with doxapram. Cli Pharmacol Ther. 2001;70:540-5.
17. Onishi S, Iikura Y, Ushiyama M. The state of pediatric therapy in Japan. Jpn J Dev Pharmacol Ther. 1996;9:95-9 (in Japanese).
18. Savelieva I, Yap YG, Yi G, Guo XH, Hnatkova K, Camm AJ, et al. Relation of ventricular repolarization to cardiac cycle length in normal subjects, hypertrophic cardiomyopathy, and patients with myocardial infarction. Clin Cardiol. 1999;22:649-54.
19. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med. 1998;338:1709-14.
20. Yamazaki T, Kajiwara M, Itahashi K, Fujimura M. Low-dose doxapram therapy for idiopathic apnea prematurity. Pediatr Inter. 2001;43:124-7.